If you've been comparing tirzepatide prices, you've probably noticed two brand names: Mounjaro (for diabetes) and Zepbound (for weight loss). They're the same molecule, the same doses, the same injection β just different labels and different insurance treatment.
Price Comparison
| Pricing Pathway | Mounjaro (Diabetes) | Zepbound (Weight Loss) |
|---|---|---|
| List price | $1,023/mo | $1,059/mo |
| LillyDirect vials self-pay | Not available | $299β449/mo |
| LillyDirect KwikPen | Not available | $299β449/mo |
| Insurance for diabetes | Broadly covered | Not indicated |
| Insurance for weight loss | Off-label (rare) | ~40% of plans |
| Medicare Bridge (July 2026+) | Covered for diabetes | $50/mo (KwikPen only) |
| Commercial savings card | As low as $25/mo | As low as $25/mo |
The Strategic Choice
If you have type 2 diabetes: ask your doctor about Mounjaro. Insurance coverage for diabetes is significantly broader, and with a savings card, your copay could be as low as $25/month.
If you don't have diabetes: Zepbound through LillyDirect starts at $299/month, or compounded tirzepatide starts at $179/month.
| Provider | Starting Price | Details |
|---|---|---|
| Yucca Health | $149/mo | Check Price β Paid link |
| Novi | $174/mo | Check Price β Paid link |
| Synergy Rx | $199/mo | Check Price β Paid link |
Key Takeaways
- Same drug: tirzepatide by Eli Lilly
- Mounjaro (diabetes) has much broader insurance coverage
- Zepbound (weight loss) available via LillyDirect at $299β449/month
- Medicare Bridge covers Zepbound KwikPen at $50/month starting July 2026
- Compounded tirzepatide from $179/month is cheapest for cash-pay
Compare All GLP-1 Prices
See today's lowest verified prices from vetted telehealth providers.
Compare Prices →